Journal article Open Access

Resistance to ceftaroline - 2018 review

Ślusarczyk, Rafał; Bielejewska, Ada; Bociek, Arkadiusz; Bociek, Martyna

Ceftaroline is a new fifth generation cephalosporin, active mostly against Gram-positive cocci, e.g. Staphylococcus aureus (including methicillin-resistant Staphylococcus aureus). It is used in treating acute bacterial skin and skin structure infections, community acquired respiratory tract infections and methicillin-resistant S. aureus bacteremia. The main resistance mechanisms of bacteria to β-lactam antibiotics, including ceftaroline, are mutations in PBP2a, PBP3 and PBP4. Clinically significant resistance has been noted among both archived and newly-isolated strains in a laboratory test using serial passages. Ceftaroline-resistant strains have also been found in patients suffering from cystic fibrosis, ventilator-associated pneumonia and infectious endocarditis. Irresponsible antibiotic treatment using ceftaroline or other antibiotics (due to a possibility of a cross-resistance) can lead to the spread of ceftaroline resistance and, consequently, its loss of value.

Files (141.0 kB)
Name Size
EJBR2018v8i3art112-120.pdf
md5:90c755ce62b51d2cab2d828359cdf483
141.0 kB Download
5
3
views
downloads
All versions This version
Views 55
Downloads 33
Data volume 423.1 kB423.1 kB
Unique views 55
Unique downloads 33

Share

Cite as